The Cross-Bridge Cycle & ATP Use
A muscle in rigor mortis is locked stiff within hours of death. It cannot relax no matter what you do to it. Why should the absence of ATP make a muscle rigid rather than limp? The answer sits at the heart of how muscles actually generate force. Myosin heads need ATP not to contract, but to let go. This single fact reorganizes everything a student thinks they know about movement. ATP powers detachment as much as it powers the stroke itself. The Sliding-Filament Mechanism describes the visible consequence of contraction. Thin filaments slide past thick filaments, sarcomeres shorten, muscle fibers generate tension. But sliding filaments do not slide themselves. The molecular engine that drags actin past myosin is the cross-bridge cycle. It is a repeating, ATP-driven sequence of attachment, rotation, and release. Millions of myosin heads perform this cycle asynchronously within a single sarcomere. Understanding this cycle converts the sliding-filament story from a description into an explanation. It tells you why filaments slide, and how fast they can slide. It also explains why muscle needs a continuous fuel supply even to stay contracted. This topic matters far beyond a single classroom diagram. The cross-bridge cycle is the mechanistic foundation for muscle fatigue and rigor mortis. It also underlies the sliding-filament theory's quantitative predictions about force and shortening velocity. Clinical phenomena depend on it too, from myosin-inhibiting drugs to genetic cardiomyopathies caused by mutant myosin heads. It is also the conceptual bridge to Excitation-Contraction Coupling (how calcium turns the cycle on). It likewise connects to Muscle Mechanics: Length-Tension & Force-Velocity (how cycling kinetics set the limits of muscle performance). This article walks through the five-step cycle in molecular detail. It explains the biochemical evidence, including the classic in vitro motility assays. It also covers the X-ray diffraction studies that revealed the power stroke. The article then works through two quantitative examples. One calculates ATP consumption during a sustained contraction. The other reasons through the physiology of rigor mortis.
- The cross-bridge cycle is the repeating molecular sequence — attach, power stroke, detach, re-cock — by which myosin heads pull actin filaments toward the sarcomere center.
- ATP hydrolysis (not binding) cocks the myosin head into its high-energy conformation; ATP binding to myosin, not hydrolysis, is what breaks the actin-myosin bond.
- Without ATP, myosin heads stay locked onto actin — this is the molecular basis of rigor mortis.
- Calcium binding to troponin C removes tropomyosin's blockade of myosin-binding sites on actin, permitting the cycle to proceed.
- Each cycle consumes exactly one ATP molecule per myosin head, regardless of whether the muscle shortens or merely holds isometric tension.
- Classic evidence includes Lymn-Taylor kinetic biochemistry, Huxley's X-ray diffraction of the power stroke, and single-molecule optical-trap experiments measuring force per cross-bridge.
ATP binding — not hydrolysis — detaches myosin from actin, so a muscle deprived of ATP cannot relax; it locks into rigor.
The core idea
The cross-bridge cycle is the molecular mechanism underlying the sliding-filament model of muscle contraction. A "cross-bridge" is the myosin head (the globular S1 subfragment) projecting from a thick filament, capable of binding actin, hydrolyzing ATP, and rotating on a flexible lever arm. Contraction is not a single event but the statistically averaged, asynchronous cycling of hundreds of thousands of these heads per sarcomere, each independently attaching to actin, executing a small angular rotation called the power stroke, and releasing — over and over, roughly 5 to 50 times per second depending on fiber type, for as long as calcium and ATP are available. Two biochemical facts anchor the entire mechanism, and both are frequently inverted by students. First, ATP hydrolysis energizes the head but does not by itself generate force — hydrolysis re-cocks myosin into a strained, high-energy conformation before it rebinds actin. Second, the power stroke itself is triggered by phosphate release after the head has already bound actin, and it is this stroke, not the hydrolysis step, that pulls the thin filament. The distinction between "energizing" and "force-generating" steps is the conceptual key to the whole cycle and explains why muscle can hold isometric tension (cycling continues, ATP is consumed, but no shortening occurs because the load resists sliding). The cycle operates within the sarcomere architecture established by the sliding-filament model: thick filaments of myosin interdigitated with thin filaments of actin, tropomyosin, and the troponin complex, anchored between Z-discs. What the cross-bridge cycle adds is the molecular engine — the chemistry and mechanics that convert the chemical energy of ATP into the mechanical energy of directed force, at an efficiency of roughly 40–50% (the rest dissipated as heat, which is why muscles warm the body during exercise).
Mechanism — step by step
The cycle is conventionally described in five stages, forming a closed loop. Take myosin's ATPase site as the reference point.
Step 1 — Rigor/attached state (starting reference). Immediately after the power stroke, myosin is tightly bound to actin at a low angle, having just completed force generation. No nucleotide occupies the myosin head. This is the "rigor" configuration — the same state responsible for rigor mortis when ATP is unavailable.
Step 2 — ATP binding and detachment. ATP binds the myosin head's nucleotide pocket. This binding event causes a conformational change in the actin-binding cleft of myosin that sharply lowers its affinity for actin, causing immediate dissociation. This is the crucial, counter-intuitive fact: ATP binding breaks the cross-bridge, not hydrolysis and not the power stroke. A muscle with zero ATP cannot execute this step, so myosin heads remain frozen onto actin.
Step 3 — ATP hydrolysis and re-cocking. With myosin detached, its intrinsic ATPase activity hydrolyzes ATP to ADP and inorganic phosphate (Pi). Both products remain bound to the head. Hydrolysis releases energy that is stored mechanically: the lever arm (the neck region of myosin) rotates roughly 60–70° relative to the catalytic domain, swinging the head into a "cocked," high-energy conformation — analogous to pulling back a spring-loaded hammer. This is the myosin weak-binding state: the head can now touch actin loosely, without generating force yet.
Step 4 — Cross-bridge formation and phosphate release. The cocked myosin head binds weakly to a new actin monomer, farther along the thin filament than its previous attachment site. Binding triggers release of inorganic phosphate from the active site. Pi release is the trigger for the power stroke: the lever arm snaps from its cocked ~90° angle to roughly 45°, dragging the attached actin filament toward the sarcomere's M-line by about 10 nanometers per stroke (values commonly cited range 5–10 nm depending on measurement method and species). This is the actual force-generating, filament-sliding event.
Step 5 — ADP release and return to rigor. After the power stroke, ADP is released from the myosin head, returning it to the strongly bound, low-energy rigor configuration described in Step 1 — poised to bind fresh ATP and repeat the cycle. Several quantitative and mechanistic points deserve emphasis:
- One ATP per cycle. Each full turn of the cycle — one attachment/power-stroke/detachment sequence — consumes exactly one ATP molecule, irrespective of whether the sarcomere shortens (isotonic) or stays fixed length (isometric). Isometric contraction still burns ATP because heads cycle against an immovable load; force is maintained by continuous re-attachment of new cross-bridges as others detach (asynchronous cycling keeps net tension roughly constant).
- Duty cycle. At any instant, only a fraction of available myosin heads — roughly 20–40% for fast skeletal myosin under load — are actually attached to actin; the rest are in the detached, hydrolysis, or re-cocking states. This asynchrony is essential: if every head detached simultaneously, tension would drop to zero periodically instead of being smoothly maintained.
- Regulation is separate from the cycle itself. The cycle can only proceed if myosin-binding sites on actin are exposed. At rest, tropomyosin physically blocks these sites, held in place by the troponin complex (troponin C, I, and T). When cytosolic Ca²⁺ rises (covered fully under Excitation-Cont raction Coupling), Ca²⁺ binds troponin C, causing a conformational shift that moves tropomyosin deeper into the actin groove, exposing binding sites and permitting Step 4 to occur. This regulatory switch, not the cross-bridge chemistry, is what determines whether contraction happens at all.
The evidence
The cross-bridge cycle was not deduced from anatomy alone; it was reconstructed from decades of converging biochemical, structural, and single-molecule physics.
Lymn and Taylor (1971) — the kinetic scheme. Richard Lymn and Edwin Taylor performed rapid-mixing biochemical kinetics on isolated myosin and actin in solution, measuring the rates of ATP binding, hydrolysis, and phosphate/ADP release both with and without actin present. Their central finding: myosin's ATPase activity is drastically accelerated when actin is present (actin acts as a cofactor), but crucially, ATP addition to actomyosin caused immediate dissociation of the complex — measurable as a sudden drop in solution viscosity and light scattering, occurring within milliseconds, far faster than the hydrolysis step itself. This established that ATP binding — not hydrolysis — is the dissociating event, the finding that structures Step 2 above. Lymn and Taylor's 1971 model (published in Biochemistry) remains the kinetic backbone of the modern cross-bridge cycle.
Huxley's X-ray diffraction studies (1950s–1970s). Sir Andrew Huxley and Hugh Huxley (unrelated), pioneers of the sliding-filament model itself, extended their work using low-angle X-ray diffraction on live, contracting muscle. Contracting muscle showed a measurable, transient change in the diffraction pattern's meridional and layer-line reflections consistent with myosin heads tilting relative to the thick filament axis during force generation — direct physical evidence that the myosin head changes angle, supporting the swinging-lever-arm model of the power stroke rather than a static "grab and release" mechanism with no internal motion.
In vitro motility assays (Spudich, Sheetz, and colleagues, 1980s). Purified myosin was attached to a glass coverslip, and fluorescently labeled actin filaments were laid over it in a buffer containing ATP. Under video microscopy, the actin filaments were observed to glide across the myosin-coated surface at measurable velocities (on the order of micrometers per second) purely from ATP hydrolysis by myosin — no other cellular machinery required. This proved that the myosin head alone is a sufficient molecular motor: sliding does not require intact sarcomere architecture, membranes, or accessory proteins beyond actin, myosin, and ATP.
Single-molecule optical trap experiments (Finer, Simmons, and Spudich, 1994). Using laser optical tweezers to hold a single actin filament taut between two polystyrene beads and lowering it onto a single myosin molecule fixed to a third bead, the researchers directly measured individual power-stroke events: displacements averaging roughly 11 nanometers and forces of roughly 3–4 piconewtons per cross-bridge cycle. This was the first direct measurement of a single molecular motor's mechanical output, confirming the magnitude of the power stroke predicted by structural and kinetic models.
Rigor mortis as a natural experiment. Perhaps the most intuitive confirmation is clinical/physiological: after death, cellular ATP production ceases (no oxidative phosphorylation, glycolysis exhausts its substrate), and intracellular Ca²⁺ rises uncontrolled as membrane pumps fail, allowing calcium to activate the thin filament while no ATP remains to detach cross-bridges once formed. The muscle locks in the rigor (Step 1) configuration — exactly as predicted if ATP binding is required for detachment. Rigor typically onsets 2–6 hours post-mortem and resolves after roughly 24–72 hours as proteolytic enzymes degrade the muscle proteins themselves.
Worked examples
Example 1 — Quantifying ATP consumption during sustained isometric contraction. Suppose a single fast-twitch skeletal muscle fiber contains approximately 6 × 10¹⁷ myosin heads per gram of muscle tissue (a physiologically reasonable order-of-magnitude estimate based on myosin content of ~150 mg/g wet muscle and molecular mass considerations). During a sustained isometric tetanic contraction, each cycling head completes roughly 5 cross-bridge cycles per second (a typical cycling rate for cycling heads in fast-twitch fibers under load, reflecting Step 3–5 kinetics), and at any instant roughly 30% of heads are in the attached, cycling pool (duty cycle ≈ 0.3), the rest awaiting calcium-permitted engagement or in transient detached states. ATP consumed per gram per second:
Converting to moles (Avogadro's number ≈ 6.02 × 10²³/mol):
This is squarely within the experimentally measured range for tetanic mammalian skeletal muscle (typically cited as 0.5–3 μmol ATP·g⁻¹·s⁻¹ depending on fiber type and temperature), demonstrating that the cross-bridge cycle's "one ATP per cycle" rule, scaled up across the enormous number of heads in a muscle, quantitatively accounts for measured metabolic rates during contraction. It also explains why isometric contraction — no visible shortening at all — still burns substantial ATP: heads are cycling against an immovable load, repeatedly attaching, stroking, and detaching without net filament displacement.
Example 2 — Reasoning through rigor mortis and a clinical parallel (malignant hyperthermia). A forensic pathologist notes that a body shows onset of rigor mortis roughly 3 hours after death and full rigidity by 8 hours, resolving by about 48 hours. Explain the timeline mechanistically, and contrast it with the pathophysiology of malignant hyperthermia, a pharmacogenetic emergency. Rigor mortis reasoning: After circulatory arrest, oxygen delivery ceases, halting oxidative phosphorylation; anaerobic glycolysis continues briefly using stored glycogen, but ATP and creatine phosphate reserves are finite and typically exhausted within 1–4 hours depending on pre-mortem glycogen stores and ambient temperature. As ATP falls, the SR Ca²⁺-ATPase (which normally pumps calcium back into the sarcoplasmic reticulum to relax the muscle) fails, calcium leaks into the cytosol and binds troponin C, exposing actin's myosin-binding sites. Any myosin heads still holding ADP+Pi complete their power stroke and bind actin, but because no ATP remains, Step 2 (ATP binding → detachment) cannot occur. Heads accumulate irreversibly in the rigor configuration, and because thousands of cross-bridges lock per sarcomere, the whole muscle becomes rigid. Resolution of rigor after 24–72 hours occurs not through any cross-bridge chemistry but through autolysis: intracellular proteases (calpains, cathepsins) degrade the myofilament proteins themselves once cellular compartmentalization breaks down, mechanically destroying the rigid cross-bridges rather than cycling them off enzymatically. Malignant hyperthermia contrast: This is a genetic disorder (commonly involving RYR1, the skeletal muscle ryanodine receptor, though this specific gene name is given only as the well-established clinical association) triggered by certain volatile anesthetics or succinylcholine, causing massive, uncontrolled Ca²⁺ release from the sarcoplasmic reticulum. Unlike rigor mortis, ATP is still abundant (the patient is alive), so cross-bridges cycle continuously and uncontrollably — consuming ATP at a runaway rate, generating enormous heat as a byproduct of futile cycling (recall the 40–50% efficiency figure — the rest is heat), causing dangerous hyperthermia, acidosis, and potentially fatal muscle rigidity if untreated. The contrast is instructive: rigor mortis is cross-bridges stuck attached due to ATP absence; malignant hyperthermia is cross-bridges cycling excessively due to ATP abundance and uncontrolled calcium — same molecular machine, opposite failure mode.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "ATP hydrolysis powers the power stroke directly." | Hydrolysis re-cocks the head (Step 3); the power stroke is triggered by Pi release after actin rebinding (Step 4). |
| "ATP causes muscle to contract; without it muscle goes limp." | ATP is required to detach myosin. Without ATP, muscle stays rigidly contracted (rigor), not limp. |
| "All myosin heads in a sarcomere cycle in synchrony." | Cycling is asynchronous and stochastic; this asynchrony is what allows smooth, sustained tension rather than pulsatile jerks. |
| "Calcium directly powers the cross-bridge cycle." | Calcium is a regulatory switch (via troponin-tropomyosin) that permits the cycle; ATP is the energy source. |
| "Isometric contraction uses no ATP because there's no movement." | Isometric contraction still consumes ATP — heads cycle against a fixed load without net shortening. |
| "One ATP powers one full muscle contraction." | One ATP powers one cross-bridge cycle of one myosin head; a whole-muscle contraction involves astronomically many simultaneous cycles. |
The scientist behind it
Origins · 1 minAndrew F. Huxley and how this was discovered
Andrew Huxley, a physiologist and biophysicist (and half-brother of writer Aldous Huxley's family line through their shared grandfather Thomas Henry Huxley), co-developed the sliding-filament model in 1954 alongside Rolf Niedergerke, working independently but simultaneously with Hugh Huxley and Jean Hanson. He went on to build detailed mathematical and structural models of how myosin cross-bridges generate force, using mechanical measurements, X-ray diffraction, and rigorous kinetic modeling. Alongside his contributions to muscle physiology, Huxley shared the 1963 Nobel Prize in Physiology or Medicine with Alan Hodgkin and John Eccles for work on nerve impulse conduction — the ionic basis of the action potential — making him one of the rare scientists to leave foundational marks on two entirely separate areas of physiology.
Where this matters today
Cardiac pharmacology. Drugs such as omecamtiv mecarbil directly target the myosin cross-bridge cycle, prolonging the attached, force-generating state of cardiac myosin to boost contractility in heart failure — a direct clinical application of cross-bridge kinetics. Conversely, mavacamten, approved for hypertrophic cardiomyopathy, works by reducing the number of myosin heads available to cycle, easing excessive contractility caused by mutant myosin genes.
Genetic cardiomyopathy diagnosis. Many cases of hypertrophic and dilated cardiomyopathy trace to point mutations in genes encoding myosin heavy chain or myosin-binding protein C, altering cross-bridge cycling kinetics (duty cycle, power stroke efficiency, or ATPase rate) — understanding the normal cycle is prerequisite to interpreting these pathologies.
Anesthesiology and critical care. Recognizing the mechanistic contrast between rigor (ATP absence) and malignant hyperthermia (uncontrolled cycling) informs both forensic time-of-death estimation and emergency anesthetic management protocols (e.g., dantrolene, which blocks the ryanodine receptor to halt runaway Ca²⁺ release in malignant hyperthermia).
Biotechnology and nanotechnology. In vitro motility assays and single-molecule optical trap techniques developed to study the cross-bridge cycle are now standard tools for studying other cytoskeletal motors (kinesin, dynein), and myosin-actin systems have inspired synthetic molecular motor design in nanotechnology.
Exercise physiology and fatigue research. Understanding ATP turnover per cross-bridge cycle underlies models of muscular fatigue, informing training science, ergogenic aid research (creatine phosphate supplementation extends short-term ATP regeneration), and rehabilitation medicine.
Agricultural and food science. Rigor mortis kinetics in livestock directly affect meat tenderness; controlling post-slaughter ATP depletion rate and calcium handling is a genuine variable in meat processing science.
Ask the tutor: How does the cross-bridge cycle's kinetics quantitatively shape the force-velocity relationship in different muscle fiber types?
Does the cross-bridge cycle require calcium directly, or only indirectly?
Only indirectly. Calcium does not participate in the chemistry of the cross-bridge cycle itself — it never binds myosin or hydrolyzes ATP. Instead, calcium binds troponin C, causing tropomyosin to shift position on the actin filament and expose myosin-binding sites that were previously blocked. Once sites are exposed, the cycle (ATP binding, hydrolysis, attachment, power stroke, detachment) proceeds using its own independent chemistry, entirely powered by ATP. Removing calcium (via SR Ca²⁺-ATPase pumping it back into the sarcoplasmic reticulum) re-covers the binding sites and halts new cross-bridge formation, causing relaxation — but existing cycles still require ATP binding to complete detachment.
Why does isometric contraction consume ATP if the muscle isn't shortening?
Isometric contraction means the whole muscle's length is fixed, typically because the load equals or exceeds the force the muscle can generate. But individual sarcomeres and cross-bridges are still cycling: myosin heads attach, attempt a power stroke, and detach, repeatedly, even though the net filament position doesn't advance because the external load prevents net sliding. Tension is maintained because many heads are cycling asynchronously — as some detach, others attach — keeping total force roughly constant. Each of these cycles still consumes one ATP, which is why isometric exercise (like holding a plank) is metabolically costly despite no visible movement.
What is the "duty cycle" of a myosin head, and why does it matter?
The duty cycle is the fraction of the total cross-bridge cycle time during which a myosin head is actually bound to actin (as opposed to detached, hydrolyzing ATP, or re-cocking). For fast skeletal myosin under load, duty cycle is roughly 20–40%. A low duty cycle means many myosin heads must act in parallel to sustain continuous tension, since any single head spends most of its cycle detached. Muscle types differ: some myosin isoforms (like those in smooth muscle or slow-twitch fibers) have higher duty cycles and slower cycling rates, trading speed for economy and sustained force — a key link to Muscle Mechanics: Length-Tension & Force-Velocity.
How does the cross-bridge cycle explain the maximum shortening velocity of a muscle?
Shortening velocity is limited by how fast individual cross-bridges can complete their cycle — specifically the rate-limiting biochemical steps (ADP release and reattachment). Because each cycle displaces the thin filament by a fixed small distance (roughly 5–10 nm) regardless of load, the maximum possible shortening velocity is set by how many cycles per second a head can complete when unopposed by load. Under heavy load, cross-bridges spend longer in the strongly bound state, slowing net cycling and shortening velocity — this relationship is formalized quantitatively in the force-velocity curve.
Does each myosin molecule have only one head, or two, and does it matter for the cycle?
Each myosin II molecule (the type in skeletal and cardiac muscle) has two globular heads, forming a dimeric "double-headed" structure at the end of its coiled-coil tail. Biochemically and mechanically, however, the two heads of a single myosin molecule typically act largely independently within the cross-bridge cycle model described here, each binding actin and cycling separately (whether the two heads cooperate mechanically remains an active research question, and some models show partial coordination). For introductory mechanistic purposes, the cycle is treated per individual head.
Is the cross-bridge cycle the same in cardiac and smooth muscle?
The core chemistry (ATP binding causes detachment, hydrolysis re-cocks, Pi release triggers the stroke) is conserved across all muscle types, since it reflects the fundamental biochemistry of the myosin ATPase. What differs is regulation and kinetics: cardiac muscle uses the same troponin-tropomyosin calcium switch as skeletal muscle but with different myosin isoforms and slower overall cycling; smooth muscle instead regulates the cycle mainly through myosin light-chain phosphorylation (calcium activates calmodulin, which activates myosin light-chain kinase) rather than exposing actin sites via troponin, since smooth muscle lacks troponin altogether.
What would happen if a mutation made myosin's ATP-binding pocket nonfunctional?
If myosin could no longer bind ATP, Step 2 of the cycle (detachment) could never occur. Any myosin heads bound to actin at the time of the mutation's effect would remain permanently attached — functionally identical to a permanent, localized rigor state in that muscle tissue, regardless of calcium levels or metabolic ATP availability elsewhere in the cell. This illustrates why myosin ATPase mutations are so functionally severe and why several inherited myopathies and cardiomyopathies trace directly to mutations affecting the ATP-binding or catalytic domain of myosin heavy chain.